Drug recall · February 23, 2022
Erythromycin Topical Gel USP recall
Why: Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.
- Lots / codes
Lot: 15724, Exp. 06/2022
- Quantity
- 11040 tubes
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Nationwide in the USA.
- Initiated
- February 7, 2022 · Voluntary: Firm initiated
- Classified
- March 24, 2022
- Reported
- February 23, 2022
- Ended
- May 9, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Erythromycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.